The Sell-Side Weighs In: Was The Exact Sciences Sell-Off Overdone? By: Benzinga via Benzinga January 17, 2018 at 16:14 PM EST EXACT Sciences Corporation (NASDAQ: EXAS) stock tumbled nearly 10 percent Wednesday after the American Society of Clinical Oncology ... Read More >> Related Stocks: Exact Sciences Cor